Publicaciones en colaboración con investigadores/as de National Institutes of Health (14)

2023

  1. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies

    The Lancet. Public health, Vol. 8, Núm. 9, pp. e691-e700

  2. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium

    Journal of Thoracic Oncology, Vol. 18, Núm. 3, pp. 313-323

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 3, pp. 679-687

2021

  1. A reply to “Lung cancer outcomes: Are BMI and race clinically relevant?”

    Lung Cancer

  2. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients

    Lung Cancer, Vol. 152, pp. 58-65

2019

  1. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium

    Journal of Thoracic Oncology, Vol. 14, Núm. 9, pp. 1594-1607

2016

  1. Prenatal ambient air pollution, placental mitochondrial DNA content, and birth weight in the INMA (Spain) and ENVIRONAGE (Belgium) birth Cohorts

    Environmental Health Perspectives, Vol. 124, Núm. 5, pp. 659-665

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

  2. Maternal occupation during pregnancy, birth weight, and length of gestation: Combined analysis of 13 European birth cohorts

    Scandinavian Journal of Work, Environment and Health, Vol. 41, Núm. 4, pp. 384-396

2014

  1. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

    PLoS ONE, Vol. 9, Núm. 6

2012

  1. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 13, pp. 4974-4979

2010

  1. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: A multicentre, randomised, placebo-controlled phase 3 study

    The Lancet Oncology, Vol. 11, Núm. 6, pp. 521-529

2007

  1. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk

    Carcinogenesis, Vol. 28, Núm. 8, pp. 1788-1793